Tertiary Hyperparathyroidism
ICD-10 E21.2 · ICD-11 5A51.Y

Treatment of Tertiary Hyperparathyroidism When Medical Management Has Failed to Control Hypercalcemia

Tertiary hyperparathyroidism (THPT) arises when autonomous parathyroid function persists despite correction of the underlying cause. When initial medical therapy does not achieve the required reduction in serum PTH and calcium, a structured next-line approach is indicated.

Previous Treatment & Failure Condition

First-line medical management — including cinacalcet HCl, and/or calcitriol, alphacalcidol therapy, and bisphosphonates — targets control of hyperparathyroidism and resolution of hypercalcemia through reduction in serum PTH and serum calcium levels. When those goals are not reached, escalation to the next therapeutic step is required.

Next-Step Approach (Partial Overview)

The established next-line intervention for THPT involves a surgical approach to the parathyroid glands. The specific operative procedure — and the accompanying techniques performed at the same setting — are detailed in the full structured regimen.

Selection criteria, full procedural details, and perioperative considerations are available in the complete protocol.

Treatment Goals

Rapid reduction in serum PTH and calcium levels; relief of hyperparathyroidism symptoms including bone pain, depression, itching, and easy fatigue; and improvement in trabecular bone mineral content.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.5005/jp-journals-10002-1033

  • As same as dialysis patients with advanced SHPT, PTx is the most successful treatment for resolving advanced HPT in patients with THPT.
  • Subtotal PTx and total PTx with autograft are widely accepted for THPT.
  • Our preferable operative procedure for THPT is total PTx with forearm autograft.
  • Simultaneous thymectomy, resection of thymic tongues from neck incision is performed routinely.
  • After PTx, serum PTH and calcium levels drop rapidly because autografted parathyroid tissue begins functioning after two to three weeks after PTx, and usually patients have severe hungry bone syndrome, and calcium and phosphorus move to bone from blood and bone formation becomes prominent.
  • The bone mineral content in trabecular bone measured by X-ray absorptiometry has increased about 10% after PTx, and fracture risk has been lower.
  • Symptoms of HPT, i.e. bone pain, depression, itching, easy fatigue, etc., have been efficiently relieved by successful PTx.
View source ↗